ial Library Secures $10M to Democratize Clinical Trial Access
December 15, 2025, 9:38 pm
Trial Library, a San Francisco-based AI platform, just raised $10 million in Series A funding. This investment aims to expand access to clinical trials *outside* major research hospitals. The company focuses on community-based care. It uses AI to connect patients with relevant trials. Investors see a shift towards decentralized research. Trial Library’s platform boosts patient recruitment for pharmaceutical companies. It also benefits patients seeking cutting-edge treatment options. The funding will fuel network growth and platform development.
---
Trial Library is changing how patients access clinical trials. The company recently closed a $10 million Series A round. SemperVirens Venture Capital and Next Ventures co-led the funding. Sanofi Ventures, Lux Capital, and others participated. Total funding now reaches $15 million.
The problem is clear. Most cancer patients—85%—receive care in community settings. Yet, clinical trials happen primarily at large institutions. This creates a significant access gap. Trial Library intends to bridge it.
Their solution? An AI-powered platform. It activates providers. It identifies eligible patients. It navigates the complex trial process. This isn’t just about technology. It’s about making trials a standard care option.
The company already operates in over 320 clinics. It works with 1,500+ providers nationwide. Partnerships with payers are expanding. Self-insured plans and health plans are key. They see trial access as a valuable benefit.
Investors recognize a larger trend. Decentralized research is gaining momentum. Pharmaceutical companies need faster, more diverse recruitment. Trial Library delivers. It streamlines the process. It broadens patient participation.
The $10 million will accelerate growth. Expect expansion of the clinic network. Stronger payer partnerships are planned. Continued platform development is crucial. Trial Library aims to make clinical trial access universal.
This isn’t just about research. It’s about patient care. It’s about giving everyone a chance at precision medicine. Trial Library is positioned to lead this change. The future of clinical trials is here. It’s in the community. It’s powered by AI. And it’s accessible to all.
**Keywords:** Clinical Trials, AI, Healthcare, Funding, Venture Capital, Precision Medicine, Community Healthcare, Digital Health, San Francisco, Trial Library, Next Ventures, SemperVirens Venture Capital, Sanofi Ventures, Lux Capital, Patient Access, Decentralized Trials.
---
Trial Library is changing how patients access clinical trials. The company recently closed a $10 million Series A round. SemperVirens Venture Capital and Next Ventures co-led the funding. Sanofi Ventures, Lux Capital, and others participated. Total funding now reaches $15 million.
The problem is clear. Most cancer patients—85%—receive care in community settings. Yet, clinical trials happen primarily at large institutions. This creates a significant access gap. Trial Library intends to bridge it.
Their solution? An AI-powered platform. It activates providers. It identifies eligible patients. It navigates the complex trial process. This isn’t just about technology. It’s about making trials a standard care option.
The company already operates in over 320 clinics. It works with 1,500+ providers nationwide. Partnerships with payers are expanding. Self-insured plans and health plans are key. They see trial access as a valuable benefit.
Investors recognize a larger trend. Decentralized research is gaining momentum. Pharmaceutical companies need faster, more diverse recruitment. Trial Library delivers. It streamlines the process. It broadens patient participation.
The $10 million will accelerate growth. Expect expansion of the clinic network. Stronger payer partnerships are planned. Continued platform development is crucial. Trial Library aims to make clinical trial access universal.
This isn’t just about research. It’s about patient care. It’s about giving everyone a chance at precision medicine. Trial Library is positioned to lead this change. The future of clinical trials is here. It’s in the community. It’s powered by AI. And it’s accessible to all.
**Keywords:** Clinical Trials, AI, Healthcare, Funding, Venture Capital, Precision Medicine, Community Healthcare, Digital Health, San Francisco, Trial Library, Next Ventures, SemperVirens Venture Capital, Sanofi Ventures, Lux Capital, Patient Access, Decentralized Trials.